InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Wednesday, 11/06/2019 10:56:43 AM

Wednesday, November 06, 2019 10:56:43 AM

Post# of 3870
RDHL may be the only company that did not see any sustained price appreciation even after fda approval of a drug that has $1 B possible potential.
They have money, marketing approval and sales team - not weight age given to any of that
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News